Teladoc Health Inc (NYSE:TDOC) CFO Mark Hirschhorn sold 10,000 shares of the firm’s stock in a transaction on Tuesday, December 4th. The stock was sold at an average price of $64.96, for a total value of $649,600.00. Following the completion of the transaction, the chief financial officer now owns 3,285 shares in the company, valued at approximately $213,393.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Mark Hirschhorn also recently made the following trade(s):
- On Friday, November 2nd, Mark Hirschhorn sold 10,000 shares of Teladoc Health stock. The stock was sold at an average price of $70.13, for a total value of $701,300.00.
- On Tuesday, September 25th, Mark Hirschhorn sold 35,000 shares of Teladoc Health stock. The shares were sold at an average price of $80.42, for a total value of $2,814,700.00.
Shares of TDOC stock traded down $2.40 during mid-day trading on Friday, reaching $53.41. 2,297,902 shares of the stock traded hands, compared to its average volume of 1,497,695. Teladoc Health Inc has a 1-year low of $30.88 and a 1-year high of $89.05. The firm has a market capitalization of $3.91 billion, a price-to-earnings ratio of -32.37 and a beta of 0.92. The company has a current ratio of 8.99, a quick ratio of 8.99 and a debt-to-equity ratio of 0.40.
Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Thursday, November 1st. The health services provider reported ($0.34) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.36) by $0.02. Teladoc Health had a negative return on equity of 14.05% and a negative net margin of 31.32%. The firm had revenue of $111.00 million for the quarter, compared to analyst estimates of $109.94 million. During the same period last year, the firm posted ($0.55) earnings per share. The business’s revenue for the quarter was up 61.6% on a year-over-year basis. On average, sell-side analysts predict that Teladoc Health Inc will post -1.47 earnings per share for the current fiscal year.
Hedge funds have recently made changes to their positions in the company. Harvest Fund Management Co. Ltd acquired a new stake in shares of Teladoc Health during the third quarter valued at about $165,000. Signaturefd LLC acquired a new stake in shares of Teladoc Health during the third quarter valued at about $173,000. Aperio Group LLC acquired a new stake in shares of Teladoc Health during the second quarter valued at about $201,000. California Public Employees Retirement System acquired a new stake in shares of Teladoc Health during the second quarter valued at about $203,000. Finally, D.A. Davidson & CO. acquired a new stake in shares of Teladoc Health during the third quarter valued at about $210,000.
A number of research analysts have issued reports on the company. Jefferies Financial Group set a $95.00 target price on Teladoc Health and gave the company a “buy” rating in a research report on Friday, November 2nd. Chardan Capital lifted their target price on Teladoc Health from $98.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, November 2nd. Craig Hallum lifted their target price on Teladoc Health from $70.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, October 15th. TheStreet cut Teladoc Health from a “c” rating to a “d+” rating in a research report on Tuesday, October 9th. Finally, Credit Suisse Group assumed coverage on Teladoc Health in a research report on Monday, October 8th. They issued a “neutral” rating and a $80.00 target price on the stock. Four investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $85.06.
COPYRIGHT VIOLATION NOTICE: “Mark Hirschhorn Sells 10,000 Shares of Teladoc Health Inc (TDOC) Stock” was originally posted by Equities Focus and is the property of of Equities Focus. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.equitiesfocus.com/2018/12/08/mark-hirschhorn-sells-10000-shares-of-teladoc-health-inc-tdoc-stock.html.
Teladoc Health Company Profile
Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Featured Article: What are Institutional Investors?
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.